| Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers A Krzeslak, K Wojcik-Krowiranda, E Forma, P Jozwiak, H Romanowicz, ... Pathology & Oncology Research 18, 721-728, 2012 | 310 | 2012 |
| O-GlcNAcylation and Metabolic Reprograming in Cancer P Jóźwiak, E Forma, M Bryś, A Krześlak Frontiers in endocrinology 5, 145, 2014 | 157 | 2014 |
| Anticancer activity of propolis and its compounds E Forma, M Bryś Nutrients 13 (8), 2594, 2021 | 137 | 2021 |
| Gene expression of O-GlcNAc cycling enzymes in human breast cancers A Krześlak, E Forma, M Bernaciak, H Romanowicz, M Bryś Clinical and experimental medicine 12, 61-65, 2012 | 124 | 2012 |
| Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α … K Starska, E Forma, P Jóźwiak, M Bryś, I Lewy-Trenda, ... Tumor Biology 36, 2309-2321, 2015 | 88 | 2015 |
| Concentration of cadmium, nickel and aluminium in female breast cancer H Romanowicz-Makowska, E Forma, M Bryś, WM Krajewska, B Smolarz Polish Journal of Pathology 62 (4), 257-261, 2011 | 79 | 2011 |
| Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level W Rozanski, A Krzeslak, E Forma, M Brys, M Blewniewski, P Wozniak, ... Clinical laboratory 58 (5), 579, 2012 | 77 | 2012 |
| Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer A Krześlak, E Forma, P Jóźwiak, A Szymczyk, B Smolarz, ... Clinical and experimental medicine 14, 107-113, 2014 | 49 | 2014 |
| Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations A Krześlak, E Forma, M Bryś, K Wójcik-Krowiranda, A Bieńkiewicz Ginekologia polska 83 (1), 2012 | 46 | 2012 |
| The potential role of O-GlcNAc modification in cancer epigenetics E Forma, P Jóźwiak, M Bryś, A Krześlak Cellular and Molecular Biology Letters 19 (3), 438-460, 2014 | 41 | 2014 |
| Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer A Krześlak, E Forma, G Chwatko, P Jóźwiak, A Szymczyk, J Wilkosz, ... Toxicology and applied pharmacology 268 (3), 278-285, 2013 | 41 | 2013 |
| Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer K Starska, E Forma, I Lewy-Trenda, O Stasikowska-Kanicka, M Skóra, ... Cellular Oncology 41, 253-268, 2018 | 40 | 2018 |
| Differential expression of ten-eleven translocation genes in endometrial cancers P Ciesielski, P Jóźwiak, K Wójcik-Krowiranda, E Forma, Ł Cwonda, ... Tumor Biology 39 (3), 1010428317695017, 2017 | 40 | 2017 |
| Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions P Jóźwiak, P Ciesielski, A Zaczek, A Lipińska, L Pomorski, M Wieczorek, ... Journal of Biomedical Science 24, 1-10, 2017 | 37 | 2017 |
| The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. K Starska, E Forma, I Lewy-Trenda, O Stasikowska, M Bryś, ... Folia Histochemica et Cytobiologica 47 (3), 401-410, 2009 | 36 | 2009 |
| Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer M Nowacka-Zawisza, E Wiśnik, A Wasilewski, M Skowrońska, E Forma, ... Analytical Cellular Pathology 2015 (1), 828646, 2015 | 34 | 2015 |
| Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells E Forma, P Jóźwiak, P Ciesielski, A Zaczek, K Starska, M Bryś, A Krześlak PLoS One 13 (6), e0198351, 2018 | 33 | 2018 |
| Analysis of DNA repair genes polymorphisms in breast cancer H Romanowicz, Ł Pyziak, F Jabłoński, M Bryś, E Forma, B Smolarz Pathology & Oncology Research 23, 117-123, 2017 | 33 | 2017 |
| Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer K Starska, E Forma, E Brzezińska-Błaszczyk, I Lewy-Trenda, M Bryś, ... Clinical and experimental medicine 15, 455-468, 2015 | 33 | 2015 |
| Relationship of urinary isoprostanes to prostate cancer occurence M Brys, A Morel, E Forma, A Krzeslak, J Wilkosz, W Rozanski, B Olas Molecular and cellular biochemistry 372, 149-153, 2013 | 33 | 2013 |
